Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of ARVO Web-based Software for Evaluating Attention-Deficit/Hyperactive Disorder (ADHD) Symptoms in Children. Prospective, Controlled Clinical Investigation

NCT05846815 is registered in ClinicalTrials.gov with Peili Vision Ltd. as lead sponsor.

NCT NCT05846815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05846815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of ARVO Web-based Software for Evaluating Attention-Deficit/Hyperactive Disorder (ADHD) Symptoms in Children. Prospective, Controlled Clinical Investigation
Lead sponsor
Peili Vision Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 6, 2023
Completion date
August 14, 2024
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder with hyperactivity